{"id":907,"date":"2016-03-04T11:32:21","date_gmt":"2016-03-04T11:32:21","guid":{"rendered":"http:\/\/trackcircle.com\/zh-hant\/?p=907"},"modified":"2016-03-04T11:35:21","modified_gmt":"2016-03-04T11:35:21","slug":"%e5%8d%a1%e5%8d%9a%e6%9b%bf%e5%b0%bc-cabozantinib-cometriq%e8%83%bd%e5%90%a6%e4%bb%a5%e6%8c%87%e5%ae%9a%e6%82%a3%e8%80%85%e8%97%a5%e7%89%a9%e4%bd%bf%e7%94%a8%e8%a8%88%e5%8a%83named-patient-program","status":"publish","type":"post","link":"https:\/\/trackcircle.com\/zh-hant\/%e5%8d%a1%e5%8d%9a%e6%9b%bf%e5%b0%bc-cabozantinib-cometriq%e8%83%bd%e5%90%a6%e4%bb%a5%e6%8c%87%e5%ae%9a%e6%82%a3%e8%80%85%e8%97%a5%e7%89%a9%e4%bd%bf%e7%94%a8%e8%a8%88%e5%8a%83named-patient-program\/","title":{"rendered":"\u5361\u535a\u66ff\u5c3c [Cabozantinib], Cometriq\u80fd\u5426\u4ee5\u6307\u5b9a\u60a3\u8005\u85e5\u7269\u4f7f\u7528\u8a08\u5283[Named Patient Program]\u9032\u53e3"},"content":{"rendered":"<p>\u7f8e\u570bFDA\u57282012\u5e7411\u670829\u65e5\u5c0d\u91dd\u5c0d\u7532\u72b6\u817a\u9ad3\u6837\u764c\uff08<em><strong>MTC<\/strong><\/em>\uff09\u7684cabozantinib-s-malate\u5361\u535a\u66ff\u5c3c\uff08\u54c1\u724c\u662fCometriq\u85e5\u7247\uff09\u4f5c\u51fa\u8a3b\u518a\u901a\u904e\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>\u7531\u65bc\u73fe\u5728\u8a72\u7522\u54c1\u9084\u6c92\u6709\u5728\u9999\u6e2f\u9032\u884c\u8a3b\u518a\uff0c \u6240\u6709\u5361\u535a\u66ff\u5c3c\u5728\u9999\u6e2f\u662f\u672a\u8a3b\u518a\u91ab\u85e5\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>\u4efb\u4f55\u4eba\u58eb\uff0c \u5982\u679c\u9700\u8981\u4ee5\u6307\u5b9a\u60a3\u8005\u85e5\u7269\u4f7f\u7528\u8a08\u5283[Named Patient Program]\u9032\u53e3\u8cfc\u8cb7\u8a72\u85e5\u7269\uff1b \u53ef\u4ee5\u548c\u6211\u5011\u806f\u7e6b\u3002 \u5982\u679c\u689d\u4ef6\u5be6\u5c6c\u7b26\u5408\uff0c \u6211\u5011\u6703\u63d0\u4f9b\u4ee3\u8fa6\u624b\u7e8c\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>\u6839\u64da\u4e00\u4e9b\u6587\u7ae0\u6240\u8868\u793a\uff0c\u5361\u535a\u66ff\u5c3ccabozantinib\u5728\u52d5\u7269\u8eab\u4e0a\u9032\u884c\u6e2c\u8a66\u6642\uff0c \u767c\u73fe\u8a72\u7522\u54c1\u5c0d\u5f85\u7684\u52d5\u7269\u7684\u76e3\u63a7\u816b\u7624\u4f7f\u7528\u64f4\u6563\u88ab\u8861\u91cf\u7684 MRI \u5728\u901a\u4fe1\u5de5\u5177\u5c0d\u5f85\u7684\u52d5\u7269\u986f\u793a\u4e86\u5728\u660e\u986f\u7684\u64f4\u6563\u7387\u7684 (ADC)\u986f\u8457\u5730\u589e\u52a0\u8207\u816b\u7624\u6bd4\u8f03\u3002 \u8207\u6b64\u540c\u6642\uff0c\u5728 ADC \u7684\u589e\u91cf\u662f\u6c34\u5206\u5b50\u7684\u589e\u52a0\u7684\u6d41\u52d5\u6027\u7684\u7d50\u679c\u5728\u9019\u500b\u816b\u7624\u7684\u548c\u986f\u793a\u95dc\u806f\u8207\u816b\u7624\u7d30\u80de\u6b7b\u4ea1\u3002 \u4e00\u81f4\u8207\u9019\u4e9b\u767c\u73fe\uff0c\u816b\u7624\u7684\u7d44\u7e54\u5b78\u8003\u8a66\u5f9e cabozantinib \u5c0d\u5f85\u7684\u52d5\u7269\u7684\u986f\u793a\u4e86\u5927\u91cf\u7684\u816b\u7624\u7d30\u80de\u6b7b\u4ea1\uff0c\u5f9e\u7d50\u679c\u53ef\u4ee5\u770b\u51fa\u5361\u535a\u66ff\u5c3ccabozantinib\u66f4\u52a0\u9032\u4e00\u6b65\u5370\u8b49\u589e\u91cf\u5728\u816b\u7624\u6240\u8b02\u7684 ADC \u548c\u53cd\u816b\u7624\u6d3b\u52d5\u4e4b\u9593\u7684\u9023\u7d50\u5224\u65b7\u3002<\/p>\n<p>\u5728\u6df1\u5c64\u7684\u7814\u7a76\u88e1\uff0c \u7d50\u679c\u6240\u8868\u793a\u5361\u535a\u66ff\u5c3cCabozantinib \u8655\u7406\u4e5f\u5c0e\u81f4\u6025\u6d41\u5e76\u4e14\u5728\u9aa8\u982d\u8f49\u79fb\u7ad9\u9ede\u6301\u7e8c TcMDp\u589e\u52a0\u7684\u6e1b\u5c11\u3002 \u6b64\u5916\uff0c\u653e\u5c04\u5b78\u60f3\u50cf\u5831\u544a\u6240\u986f\u793a\u4e86\u9aa8\u982d\u7d50\u69cb\u7684\u6b63\u5e38\u5316\uff0c\u8207\u5c0d\u978f\u819c\u7684\u9aa8\u982d\u589e\u9577\u7684\u91cd\u5927\u7684\u6e1b\u5c11\u5e76\u4e14\u589e\u52a0\u4e86\u6709\u6a6b\u9694\u7247\u7684\u9aa8\u982d\u589e\u9577\u3002 \u7d44\u7e54\u5b78\u5831\u544a\u5206\u6790\u5411\u986f\u793a\u9019\u7531\u811b\u9aa8 osteoclasts \u7684\u4e00\u500b\u975e\u5e38\u5730\u6e1b\u5c11\u7684\u7de8\u865f\u96a8\u9644\u65bc\u3002 \u9019\u4e9b\u6f5b\u4f0f\u671f\u7684\u6578\u64da\u63d0\u4f9b\u6280\u8853\u652f\u6301\u70ba\u5c0d TcMDP \u9aa8\u982d\u00a0<sup>99<\/sup>\u6383\u63cf\u548c\u64f4\u6563\u88ab\u8861\u91cf\u7684 MRI \u7684\u4f7f\u7528\u4f5c\u70ba\u76e3\u63a7\u7684\u6cbb\u7642\u56de\u61c9\u65b9\u6cd5\u5c0d\u5728\u9019\u500b\u8a3a\u6240\u7684 cabozantinib\u3002 \u9019\u6a23\u7684\u4e00\u500b\u7d50\u679c\u53ef\u4ee5\u770b\u51fa\u65b0\u85e5\u5c0d\u91dd\u5c0d\u524d\u5217\u817a\u764c\u9aa8\u982d\u8f49\u79fb\u6f5b\u4f0f\u671f\u4ee5\u53ca\u7532\u72b6\u817a\u9ad3\u6837\u764c\uff08<em><strong>MTC<\/strong><\/em>\uff09\u7684\u800c\u8a2d\u8a08\u7684\u4e00\u500b\u9f13\u821e\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>\u4ee5\u4e0a\u5206\u6790\u8cc7\u6599\u662f\u5ba2\u89c0\u8cc7\u6599\uff0c\u8207\u672c\u7db2\u7ad9\u6c92\u6709\u95dc\u4fc2\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7f8e\u570bFDA\u57282012\u5e7411\u670829\u65e5\u5c0d\u91dd\u5c0d\u7532\u72b6\u817a\u9ad3\u6837\u764c\uff08MTC\uff09\u7684cabozantinib-s-malate\u5361\u535a\u66ff\u5c3c\uff08\u54c1\u724c\u662fCometriq\u85e5\u7247\uff09\u4f5c\u51fa\u8a3b\u518a\u901a\u904e\u3002 &nbsp; \u7531\u65bc\u73fe\u5728\u8a72\u7522\u54c1\u9084\u6c92\u6709\u5728\u9999\u6e2f\u9032\u884c\u8a3b\u518a\uff0c \u6240\u6709\u5361\u535a\u66ff\u5c3c\u5728\u9999\u6e2f\u662f\u672a\u8a3b\u518a\u91ab\u85e5\u3002 &nbsp; \u4efb\u4f55\u4eba\u58eb\uff0c \u5982\u679c\u9700\u8981\u4ee5\u6307\u5b9a\u60a3\u8005\u85e5\u7269\u4f7f\u7528\u8a08\u5283[Named Patient Program]\u9032\u53e3\u8cfc\u8cb7\u8a72\u85e5\u7269\uff1b \u53ef\u4ee5\u548c\u6211\u5011\u806f\u7e6b\u3002 \u5982\u679c\u689d\u4ef6\u5be6\u5c6c\u7b26\u5408\uff0c \u6211\u5011\u6703\u63d0\u4f9b\u4ee3\u8fa6\u624b\u7e8c\u3002 &nbsp; \u6839\u64da\u4e00\u4e9b\u6587\u7ae0\u6240\u8868\u793a\uff0c\u5361\u535a\u66ff\u5c3ccabozantinib\u5728\u52d5\u7269\u8eab\u4e0a\u9032\u884c\u6e2c\u8a66\u6642\uff0c \u767c\u73fe\u8a72\u7522\u54c1\u5c0d\u5f85\u7684\u52d5\u7269\u7684\u76e3\u63a7\u816b\u7624\u4f7f\u7528\u64f4\u6563\u88ab\u8861\u91cf\u7684 MRI \u5728\u901a\u4fe1\u5de5\u5177\u5c0d\u5f85\u7684\u52d5\u7269\u986f\u793a\u4e86\u5728\u660e\u986f\u7684\u64f4\u6563\u7387\u7684 (ADC)\u986f\u8457\u5730\u589e\u52a0\u8207\u816b\u7624\u6bd4\u8f03\u3002 \u8207\u6b64\u540c\u6642\uff0c\u5728 ADC \u7684\u589e\u91cf\u662f\u6c34\u5206\u5b50\u7684\u589e\u52a0\u7684\u6d41\u52d5\u6027\u7684\u7d50\u679c\u5728\u9019\u500b\u816b\u7624\u7684\u548c\u986f\u793a\u95dc\u806f\u8207\u816b\u7624\u7d30\u80de\u6b7b\u4ea1\u3002 \u4e00\u81f4\u8207\u9019\u4e9b\u767c\u73fe\uff0c\u816b\u7624\u7684\u7d44\u7e54\u5b78\u8003\u8a66\u5f9e cabozantinib \u5c0d\u5f85\u7684\u52d5\u7269\u7684\u986f\u793a\u4e86\u5927\u91cf\u7684\u816b\u7624\u7d30\u80de\u6b7b\u4ea1\uff0c\u5f9e\u7d50\u679c\u53ef\u4ee5\u770b\u51fa\u5361\u535a\u66ff\u5c3ccabozantinib\u66f4\u52a0\u9032\u4e00\u6b65\u5370\u8b49\u589e\u91cf\u5728\u816b\u7624\u6240\u8b02\u7684 ADC \u548c\u53cd\u816b\u7624\u6d3b\u52d5\u4e4b\u9593\u7684\u9023\u7d50\u5224\u65b7\u3002 \u5728\u6df1\u5c64\u7684\u7814\u7a76\u88e1\uff0c \u7d50\u679c\u6240\u8868\u793a\u5361\u535a\u66ff\u5c3cCabozantinib \u8655\u7406\u4e5f\u5c0e\u81f4\u6025\u6d41\u5e76\u4e14\u5728\u9aa8\u982d\u8f49\u79fb\u7ad9\u9ede\u6301\u7e8c TcMDp\u589e\u52a0\u7684\u6e1b\u5c11\u3002 \u6b64\u5916\uff0c\u653e\u5c04\u5b78\u60f3\u50cf\u5831\u544a\u6240\u986f\u793a\u4e86\u9aa8\u982d\u7d50\u69cb\u7684\u6b63\u5e38\u5316\uff0c\u8207\u5c0d\u978f\u819c\u7684\u9aa8\u982d\u589e\u9577\u7684\u91cd\u5927\u7684\u6e1b\u5c11\u5e76\u4e14\u589e\u52a0\u4e86\u6709\u6a6b\u9694\u7247\u7684\u9aa8\u982d\u589e\u9577\u3002 \u7d44\u7e54\u5b78\u5831\u544a\u5206\u6790\u5411\u986f\u793a\u9019\u7531\u811b\u9aa8 osteoclasts \u7684\u4e00\u500b\u975e\u5e38\u5730\u6e1b\u5c11\u7684\u7de8\u865f\u96a8\u9644\u65bc\u3002 \u9019\u4e9b\u6f5b\u4f0f\u671f\u7684\u6578\u64da\u63d0\u4f9b\u6280\u8853\u652f\u6301\u70ba\u5c0d TcMDP \u9aa8\u982d\u00a099\u6383\u63cf\u548c\u64f4\u6563\u88ab\u8861\u91cf\u7684 MRI \u7684\u4f7f\u7528\u4f5c\u70ba\u76e3\u63a7\u7684\u6cbb\u7642\u56de\u61c9\u65b9\u6cd5\u5c0d\u5728\u9019\u500b\u8a3a\u6240\u7684 cabozantinib\u3002 \u9019\u6a23\u7684\u4e00\u500b\u7d50\u679c\u53ef\u4ee5\u770b\u51fa\u65b0\u85e5\u5c0d\u91dd\u5c0d\u524d\u5217\u817a\u764c\u9aa8\u982d\u8f49\u79fb\u6f5b\u4f0f\u671f\u4ee5\u53ca\u7532\u72b6\u817a\u9ad3\u6837\u764c\uff08MTC\uff09\u7684\u800c\u8a2d\u8a08\u7684\u4e00\u500b\u9f13\u821e\u3002 &nbsp; \u4ee5\u4e0a\u5206\u6790\u8cc7\u6599\u662f\u5ba2\u89c0\u8cc7\u6599\uff0c\u8207\u672c\u7db2\u7ad9\u6c92\u6709\u95dc\u4fc2\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[],"class_list":["post-907","post","type-post","status-publish","format-standard","hentry","category-17"],"_links":{"self":[{"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/posts\/907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=907"}],"version-history":[{"count":1,"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/posts\/907\/revisions"}],"predecessor-version":[{"id":909,"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/posts\/907\/revisions\/909"}],"wp:attachment":[{"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trackcircle.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}